Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Intratympanic gentamicin treatment for unilateral Ménière's disease: long-term follow up of a proven regime.

Wasson J, Upile N, Pfleiderer A.

J Laryngol Otol. 2013 Jan;127(1):20-4. doi: 10.1017/S0022215112002605. Epub 2012 Dec 7.

PMID:
23217984
2.
3.

Hearing results following intratympanic gentamicin perfusion for Ménière's disease.

Kyrodimos E, Aidonis I, Sismanis A.

J Laryngol Otol. 2009 Apr;123(4):379-82. doi: 10.1017/S0022215108003150. Epub 2008 Oct 28.

PMID:
18954493
4.

Intratympanic gentamicin for intractable Meniere's disease.

Perez N, Martín E, García-Tapia R.

Laryngoscope. 2003 Mar;113(3):456-64.

PMID:
12616197
5.

Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.

Bodmer D, Morong S, Stewart C, Alexander A, Chen JM, Nedzelski JM.

Otol Neurotol. 2007 Dec;28(8):1140-4.

PMID:
18084826
6.

Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.

Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.

Laryngoscope. 2007 Aug;117(8):1474-81.

PMID:
17607149
7.

Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.

Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.

Otolaryngol Head Neck Surg. 2010 Apr;142(4):570-5. doi: 10.1016/j.otohns.2009.12.009.

PMID:
20304280
8.

Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.

Driscoll CL, Kasperbauer JL, Facer GW, Harner SG, Beatty CW.

Laryngoscope. 1997 Jan;107(1):83-9.

PMID:
9001270
9.

Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.

Manrique-Huarte R, Guillén-Grima F, Perez-Fernandez N.

Otol Neurotol. 2011 Apr;32(3):461-5. doi: 10.1097/MAO.0b013e31820e6dc8.

PMID:
21317673
10.

Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.

Smith WK, Sandooram D, Prinsley PR.

J Laryngol Otol. 2006 Sep;120(9):730-5. Epub 2006 Jul 19.

PMID:
16848921
11.

Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.

Martin E, Perez N.

Otol Neurotol. 2003 Sep;24(5):800-6.

PMID:
14501459
12.

Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.

Longridge NS, Mallinson AI.

J Otolaryngol. 2000 Feb;29(1):35-9.

PMID:
10709170
13.

Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.

Helling K, Schönfeld U, Clarke AH.

Laryngoscope. 2007 Dec;117(12):2244-50.

PMID:
17909448
14.

Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.

Abou-Halawa AS, Poe DS.

Otol Neurotol. 2002 Jul;23(4):494-502; discussion 502-3.

PMID:
12170152
15.

Intratympanic gentamicin for the treatment of unilateral Meniere's disease.

Kaplan DM, Nedzelski JM, Chen JM, Shipp DB.

Laryngoscope. 2000 Aug;110(8):1298-305.

PMID:
10942130
16.

Intratympanic gentamicin therapy for intractable Ménière's disease.

De Beer L, Stokroos R, Kingma H.

Acta Otolaryngol. 2007 Jun;127(6):605-12.

PMID:
17503229
17.

Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.

Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.

Otol Neurotol. 2010 Jun;31(4):649-55. doi: 10.1097/MAO.0b013e3181dd13ac.

PMID:
20431498
18.

[The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].

Gawęcki W, Szyfter W, Lączkowska-Przybylska J, Szyfter-Harris J.

Otolaryngol Pol. 2012 Jan-Feb;66(1):20-6. doi: 10.1016/S0030-6657(12)70744-8. Polish.

PMID:
22381010
19.

Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.

Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG.

Am J Otol. 1993 May;14(3):278-82. Review.

PMID:
8372926
20.

Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.

Quaranta A, Aloisi A, De Benedittis G, Scaringi A.

Ann N Y Acad Sci. 1999 Nov 28;884:410-24.

PMID:
10842610

Supplemental Content

Support Center